Results 81 to 90 of about 76,404 (302)

Progressive hepatopathy after central division hepatectomy in a dog

open access: yesAustralian Veterinary Journal, EarlyView.
The consequences of large‐volume hepatectomy on the remaining liver in the dog are not documented. This case report documents a progressive hepatopathy after central division hepatectomy in a 10‐year‐old female Lhasa Apso dog. Serum biochemistry at presentation for chronic urinary incontinence indicated a hepatopathy, with a liver mass identified on ...
SJ Wood, GL Hosgood, F Coiacetto
wiley   +1 more source

OUTCOME OF SPLENECTOMY IN THE TREATMENT OF ITP – ONE CENTER EXPERIENCE

open access: yesHematology, Transfusion and Cell Therapy, 2021
Objective: Immune thrombocytopenia (ITP) is a disease with variable clinical presentation, requiring different treatment lines. Splenectomy is used as a second- or third-line therapy for ITP.
Weronika Lebowa   +2 more
doaj  

Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002

open access: yesBMC Infectious Diseases, 2010
Background Splenectomy is associated with increased risk for bacteremia, due to impaired clearance of bloodborne agents and to altered phagocytosis and humoral immunity.
Dodds Linda   +3 more
doaj   +1 more source

Canine Prophylactic Gastropexy: A Cross‐Sectional Study of Irish Veterinary Professionals’ Attitudes and Current Practices [PDF]

open access: yesVet Med Sci
Prophylactic gastropexy significantly reduces the risk of gastric dilatation and volvulus (GDV) in at‐risk canine patients. This study explores attitudes and practices of veterinary professionals in Ireland regarding the procedure. While the major benefit of the procedure is reduced GDV risk, ethical concerns such as its invasiveness and impact on ...
Donnelly H, Dunne K.
europepmc   +2 more sources

The role of adrenocortical steroids in reversing established homograft rejection [PDF]

open access: yes, 1964
Renal homotransplantation was performed in 8 dogs. Antirejection therapy with azathioprine (BW 57-322, Imuran) was given in doses of 2 to 7.5 mg. per kilogram per day.
Axtell, HK   +4 more
core  

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs [PDF]

open access: yes, 1993
Heterotopic hamster hearts transplanted to unmodified LEW rats underwent humoral rejection in 3 days. Survival was prolonged to a median of 4 days with 2 mg/kg/day FK506.
Cramer, D   +6 more
core   +1 more source

Iron overload in hereditary spherocytosis: Are genetic factors the cause?

open access: yesBritish Journal of Haematology, EarlyView.
Summary Non‐transfusional iron overload (IOL) in hereditary spherocytosis (HS) is poorly documented compared with other red blood cell disorders. We studied 13 HS adults with confirmed IOL to identify potential genetic factors. Using a next‐generation sequencing panel of 46 genes related to HS, anaemia and iron metabolism, we found no association ...
Lucie Donaty   +6 more
wiley   +1 more source

RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC

open access: yesMediterranean Journal of Hematology and Infectious Diseases
Objective: Immune thrombocytopenia (ITP) is an acquired immune-mediated disease that lacks an underlying etiology. Steroids are the main first-line treatment of ITP, while the second-line treatment consists primarily of splenectomy and rituximab.
Rawanda Shamoon   +2 more
doaj   +1 more source

Different clearance of KITD816V mutation and tryptase levels after haematopoietic cell transplantation in patients with systemic mastocytosis with associated haematological neoplasm

open access: yesBritish Journal of Haematology, EarlyView.
Summary The patterns of tryptase normalization, KITD816V clearance and establishment of donor cell chimerism were analysed in 13 patients with systemic mastocytosis and associated haematological neoplasm (AHN) after haematopoietic cell transplantation (HCT).
Christian Niederwieser   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy